共 50 条
- [1] Treatment patterns of triple-class refractory (TCR) multiple myeloma (MM) across the United States (US), Canada, and western Europe: A real-world observational chart review studyJOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)Goyal, Ravi K.Frugier, GaelleRombi, JulienEsterberg, LizziDavis, Keith L.Hlavacek, PatrickRen, JinmaSchepart, AlexAydin, DidemDiBonaventura, Marco
- [2] Real-world treatment patterns and outcomes of triple-class treated patients with multiple myeloma in the United StatesEXPERT REVIEW OF HEMATOLOGY, 2023, 16 (01) : 65 - 74Varughese, PrateeshSmith, RobertXue, MeiDorrow, NatalieHogea, CosminaMaiese, Eric. M.Buckingham, Trudy
- [3] Real-world treatment patterns, healthcare use and costs in triple-class exposed relapsed and refractory multiple myeloma patients in the United StatesFUTURE ONCOLOGY, 2021, 17 (05) : 503 - 515Madduri, DeepuHagiwara, MayParikh, KejalPelletier, CoreyDelea, Thomas E.Kee, AriannaChari, Ajai
- [4] Real-world treatment patterns and clinical outcomes in patients with triple-class exposed relapsed or refractory multiple myeloma in United States clinical practiceCLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S165 - S166Chari, AjaiNair, SandhyaLin, XiwuMarshall, AlexanderSlavcev, MaryKumar, Shaji
- [5] Real-World Treatment Patterns and Clinical, Economic, and Humanistic Burden in Triple-Class Refractory Multiple Myeloma: Analysis of the Connect ® Multiple Myeloma (MM) Disease RegistryBLOOD, 2021, 138Tang, DerekHari, ParameswaranRamasamy, KarthikWeisel, KatjaJoshi, PrashantLiu, LiangChe, MinHernandez, GabrielaAbonour, RafatHardin, James W.Rifkin, Robert M.Ailawadhi, SikanderLee, Hans C.Terebelo, Howard R.Durie, Brian G. M.Narang, MohitToomey, KathleenGasparetto, CristinaWagner, Lynne I.Jagannath, Sundar
- [6] Real-world treatment patterns and clinical outcomes among patients with triple-class exposed (TCE) multiple myeloma (MM)CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S177 - S178Fonseca, RafaelHarper, JenniferLe, HoaFu, AlexPatel, SaurabhWu, BingcaoZhang, Xinke
- [7] From triple-class exposed (TCE) to penta-exposed and triple-class refractory (PE-TCR): Real-world outcomes across a spectrum of advanced relapsed or refractory multiple myeloma (RRMM) patients (Pts) in the United States.JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)Delea, Thomas E.Song, XueGe, WenzhenChi, LeiEichten, CaitlinMoynahan, AaronWeycker, DerekMa, QiufeiKroog, Glenn ScottRodriguez-Lorenc, Karen
- [8] Real-World Study of Patients with Triple-Class Exposed Relapsed or Refractory Multiple Myeloma: Analysis across a Spectrum of Advanced Disease Stage Patients in the United StatesBLOOD, 2022, 140 : 5298 - 5300Ma, QiufeiSong, XueDelea, Thomas E.Kroog, Glenn S.Ge, WenzhenChi, LeiMoynahan, AaronWeycker, DerekLorenc, Karen Rodriguez
- [9] Efficacy of Treatments for Patients with Triple-Class Refractory (TCR) Multiple Myeloma (MM): Benchmark for New Agents Utilizing Real-World Data (RWD)BLOOD, 2021, 138 : 3786 - +Costa, Luciano J.Cornell, Robert FrankCallander, Natalie S.Chhabra, SaurabhLiedtke, MichaelaKansagra, AnkitGodby, Kelly N.Bal, SusanGiri, SmithMalek, EhsanKang, YubinVij, RaviUsmani, Saad Z.Hari, ParameswaranKumar, Shaji
- [10] Real-World Study of Patients with Triple-Class Exposed Relapsed/Refractory Multiple Myeloma: Analysis across a Spectrum of Advanced Disease Stage Medicare Patients in the United StatesBLOOD, 2023, 142Delea, ThomasMoynahan, AaronGe, WenzhenSong, XueKroog, Glenn S.Noguera-Troise, IreneLorenc, Karen RodriguezMa, Qiufei